Electron Capital Partners LLC cut its holdings in Xylem Inc (NYSE:XYL) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 129,528 shares of the industrial products company’s stock after selling 1,762 shares during the quarter. Xylem makes up about 1.5% of Electron Capital Partners LLC’s investment portfolio, making the stock its 16th largest position. Electron Capital Partners LLC owned approximately 0.07% of Xylem worth $8,834,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Greenleaf Trust lifted its stake in Xylem by 97.4% in the fourth quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock worth $102,000 after acquiring an additional 735 shares during the period. Invictus RG purchased a new stake in Xylem in the third quarter worth about $104,000. Hanson & Doremus Investment Management purchased a new stake in Xylem in the fourth quarter worth about $126,000. FNY Partners Fund LP lifted its stake in Xylem by 2,700.0% in the third quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after acquiring an additional 2,700 shares during the period. Finally, Dorsey & Whitney Trust CO LLC purchased a new stake in Xylem in the third quarter worth about $205,000. 85.46% of the stock is owned by institutional investors.
In other Xylem news, insider Tomas Brannemo sold 2,260 shares of the business’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $67.75, for a total value of $153,115.00. Following the completion of the transaction, the insider now directly owns 10,975 shares in the company, valued at $743,556.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Curtis J. Crawford sold 7,948 shares of the business’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $71.77, for a total transaction of $570,427.96. Following the completion of the transaction, the director now owns 55,245 shares of the company’s stock, valued at $3,964,933.65. The disclosure for this sale can be found here. Insiders sold 88,416 shares of company stock valued at $6,123,979 over the last quarter. 0.75% of the stock is currently owned by corporate insiders.
Xylem (NYSE:XYL) last announced its earnings results on Thursday, February 1st. The industrial products company reported $0.76 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.76. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. Xylem had a net margin of 7.03% and a return on equity of 17.95%. The firm’s revenue was up 16.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.66 earnings per share. equities analysts predict that Xylem Inc will post 2.92 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Thursday, February 15th will be issued a $0.21 dividend. The ex-dividend date is Wednesday, February 14th. This is an increase from Xylem’s previous quarterly dividend of $0.18. This represents a $0.84 dividend on an annualized basis and a yield of 1.06%. Xylem’s payout ratio is currently 45.65%.
A number of analysts recently weighed in on the stock. Zacks Investment Research raised shares of Xylem from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a research note on Saturday, February 10th. ValuEngine raised shares of Xylem from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Canaccord Genuity reaffirmed a “hold” rating and issued a $65.00 price objective on shares of Xylem in a research note on Monday, December 11th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $80.00 price objective on shares of Xylem in a research note on Thursday, January 4th. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $83.00 price objective on shares of Xylem in a research note on Friday, January 26th. Five analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Xylem presently has a consensus rating of “Buy” and a consensus price target of $72.42.
ILLEGAL ACTIVITY WARNING: “Xylem Inc (XYL) Stake Lessened by Electron Capital Partners LLC” was originally published by American Banking News and is the property of of American Banking News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2018/03/12/xylem-inc-xyl-stake-lessened-by-electron-capital-partners-llc.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.